TRILEPTAL Drug Patent Profile

✉ Email this page to a colleague

When do Trileptal patents expire, and what generic alternatives are available?

Trileptal is a drug marketed by Novartis and is included in two NDAs.

The generic ingredient in TRILEPTAL is oxcarbazepine. There are twenty-one drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the oxcarbazepine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Trileptal

A generic version of TRILEPTAL was approved as oxcarbazepine by GLENMARK PHARMS LTD on October 9^th, 2007.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for TRILEPTAL?
What are the global sales for TRILEPTAL?
What is Average Wholesale Price for TRILEPTAL?

Summary for TRILEPTAL

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	130
Clinical Trials:	24
Patent Applications:	5,298
Drug Prices:	Drug price information for TRILEPTAL
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for TRILEPTAL
What excipients (inactive ingredients) are in TRILEPTAL?	TRILEPTAL excipients list
DailyMed Link:	TRILEPTAL at DailyMed

Drug patent expirations by year for TRILEPTAL

Recent Clinical Trials for TRILEPTAL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dr Cipto Mangunkusumo General Hospital	Phase 4
Collaborative Care Initiative, LLC	Phase 4
Dauten Family Center for Bipolar Treatment Innovation, Massachusetts Gen Hospital	Phase 4

See all TRILEPTAL clinical trials

Pharmacology for TRILEPTAL

Drug Class	Anti-epileptic Agent
Physiological Effect	Decreased Central Nervous System Disorganized Electrical Activity

Paragraph IV (Patent) Challenges for TRILEPTAL

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
TRILEPTAL	Oral Suspension	oxcarbazepine	300 mg/5 mL	021285	1	2006-12-26
TRILEPTAL	Tablets	oxcarbazepine	150 mg, 300 mg and 600 mg	021014	1	2006-05-05

US Patents and Regulatory Information for TRILEPTAL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	TRILEPTAL	oxcarbazepine	SUSPENSION;ORAL	021285-001	May 25, 2001	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	TRILEPTAL	oxcarbazepine	TABLET;ORAL	021014-003	Jan 14, 2000	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	TRILEPTAL	oxcarbazepine	TABLET;ORAL	021014-001	Jan 14, 2000	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	TRILEPTAL	oxcarbazepine	TABLET;ORAL	021014-002	Jan 14, 2000	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TRILEPTAL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	TRILEPTAL	oxcarbazepine	TABLET;ORAL	021014-002	Jan 14, 2000	⤷ Sign Up	⤷ Sign Up
Novartis	TRILEPTAL	oxcarbazepine	SUSPENSION;ORAL	021285-001	May 25, 2001	⤷ Sign Up	⤷ Sign Up
Novartis	TRILEPTAL	oxcarbazepine	TABLET;ORAL	021014-003	Jan 14, 2000	⤷ Sign Up	⤷ Sign Up
Novartis	TRILEPTAL	oxcarbazepine	TABLET;ORAL	021014-001	Jan 14, 2000	⤷ Sign Up	⤷ Sign Up
Novartis	TRILEPTAL	oxcarbazepine	SUSPENSION;ORAL	021285-001	May 25, 2001	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for TRILEPTAL

See the table below for patents covering TRILEPTAL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
New Zealand	336946	Oxacarbazepine (10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide) film-coated tablets with median particle size 2-12 um with a max residue of 40 um sieve of up to 5%	⤷ Sign Up
Brazil	0016524		⤷ Sign Up
Taiwan	529957		⤷ Sign Up
Hungary	227807	OXACARBAZEPINE FILM-COATED TABLETS, PROCESS FOR PRODUCING THEM	⤷ Sign Up
Colombia	5261608	COMPOSICION FARMACEUTICA EN FORMA DE UNA SUSPENSION QUE COMPRENDE OXCARBAZEPINA	⤷ Sign Up
Poland	334959		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration